New Pinnacle 21 Enterprise 4.0 Eases Concern about PMDA Submissions
April 2, 2019 Released March 31, the new P21 Enterprise 4.0 provides more options for…
CertaraApril 2, 2019
Real World Evidence Marches Forward in Drug Development
The end of 2018 ushered in a flurry of new regulatory guidance and sponsor enthusiasm…
CertaraMarch 20, 2019
How to Perform IVIVC for Extremely Long Acting Drugs
Watch this webinar to learn how to use in vitro and in vivo models to…
CertaraFebruary 22, 2019
Managing Immunogenicity Using Quantitative Systems Pharmacology
The Challenge of Immunogenicity in Biologics Drug Development Biologic drug development is a rapidly evolving…
CertaraFebruary 22, 2019
PBPK’s Pivotal Role in Modern Drug Development: Busting Common Myths and Misconceptions
This white paper addresses common PBPK myths and misconceptions and demonstrates how this approach is…
CertaraFebruary 4, 2019
Define.xml Frequently Asked Questions
Discover answers to common Define.xml FAQs, covering best practices, expert tips, and essential guidance for…
CertaraDecember 10, 2018
7 Things to Know About the China Pharmaceutical Industry
China is the second largest pharmaceutical market in the world. Demand is likely to increase…
CertaraOctober 16, 2018
